Top Markets
#1 Black Phoenix Black Phoenix +21,537.33%
#2 Nesa Nesa +772.80%
#3 Cortex Cortex +68.63%
#4 Kinesis Silver Kinesis Silver +55.36%
#5 QuantixAI QuantixAI +23.76%
#6 EXOD EXOD +22.78%
#7 Derive Derive +19.90%
#8 Cash Cat Cash Cat +16.73%
#9 Pons Pons +16.53%
#10 BNB Attestation Service BNB Attestation Service +16.09%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Classifica tra le azioni #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Prezzo delle azioni
$4.62
Ultima sincronizzazione: 2023-03-23
Capitalizzazione di mercato
$171.76M
Variazione (1 giorno)
-37.16%
Variazione (1 anno)
0.00%
Paese
KR
Scambia Cellivery Therapeutics, Inc. (268600)

Categoria

Healthcare
Rapporto P/S per Cellivery Therapeutics, Inc. (268600)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cellivery Therapeutics, Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Cellivery Therapeutics, Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH